Skip to content
10-Q

Quarterly Report

ACCUSTEM SCIENCES, INC. ACUT

0001493152-24-036330

← back to feed
Filed
Sep 16, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Sep 16, 2024 11.35M sh
Current Liabilities Q2 2024 · Jun 30, 2024 $3.02M
Current Liabilities Q2 2024 · Dec 31, 2023 $2.25M
Total Liabilities Q2 2024 · Jun 30, 2024 $3.02M
Total Liabilities Q2 2024 · Dec 31, 2023 $2.25M
Current Assets Q2 2024 · Jun 30, 2024 $137.43K
Current Assets Q2 2024 · Dec 31, 2023 $129.85K
Total Assets Q2 2024 · Jun 30, 2024 $139.66K
Total Assets Q2 2024 · Dec 31, 2023 $133.9K
Shares Diluted Q2 2024 · Jun 30, 2023 11.35M sh
Shares Diluted Q2 2024 · Jun 30, 2023 11.35M sh
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$969K
Stockholders Equity Q2 2024 · Jun 30, 2023 −$1.31M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$946.68K
Stockholders Equity Q2 2024 · Dec 31, 2022 −$139.55K
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.03
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.11
Eps Basic Q2 2024 · Jun 30, 2023 −$0.03
Eps Basic Q2 2024 · Jun 30, 2023 −$0.11
Sga Expense Q2 2024 · Jun 30, 2023 $358.18K
Sga Expense Q2 2024 · Jun 30, 2023 $1.18M
Rd Expense Q2 2024 · Jun 30, 2023 $14.58K
Rd Expense Q2 2024 · Jun 30, 2023 $30.18K
Net Income Q2 2024 · Jun 30, 2023 −$372.76K
Net Income Q2 2024 · Jun 30, 2023 −$1.21M
Operating Income Q2 2024 · Jun 30, 2023 −$372.76K
Operating Income Q2 2024 · Jun 30, 2023 −$1.21M